Page 54 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 3 ฉบับที่ 1

52 «“√ “√°“√·æ∑¬å·ºπ‰∑¬·≈–°“√·æ∑¬å∑“߇≈◊Õ° ªï∑’Ë Û ©∫—∫∑’Ë Ò µÿ≈“§¡ ÚıÙ˜-¡°√“§¡ ÚıÙ¯

µ“√“ß∑’Ë 7 º≈°“√µ√«®‡π◊ÈÕ‡¬◊ËÕÕ«—¬«–∑“ß®ÿ≈欓∏‘«‘∑¬“¢ÕßÀπŸ·√∑‡æ»ºŸâ∑’ˉ¥â√—∫ “√ °—¥¬“·°â°…—¬

≈‘Èπ°√–∫◊Õ‡ªìπ‡«≈“ 3 ‡¥◊Õπ

¢π“¥¢Õß “√ °—¥¬“·°â°…—¬≈‘Èπ°√–∫◊Õ (°./°°./«—π)

Õ«—¬«– °“√‡ª≈’ˬπ·ª≈ß 0 0.5 2.5 5.0 5.0-R
n=15 n=15 n=15 n=15 n=15
ªÕ¥ Lymphoid proliferated 5/15 7/15 0/15* 1/15 4/15

peribronchioles
µ—∫ Centrilobular fatty 1/15 6/15 2/15 3/15 10/15
degeneration (+1)
°√–‡æ“– Focal gastritis 0/15 0/15 0/15 0/15 1/15

≈”‰ â‡≈Á° Lymphoid aggregated 8/15 2/15 0/15* 0/15* 1/15*
≈”‰ â„À≠à submucosa 1/15 0/15 3/15 2/15 3/15
µàÕ¡À¡«°‰µ Cortical fatty 0/15 0/15 0/15 0/15 2/15

degeneration
Nodular cortical 0/15 0/15 0/15 0/15 1/15
hyperplasia

µ—«‡≈¢„πµ“√“ß· ¥ß„π√Ÿª¢Õß ®”π«πÀπŸ∑’˵√«®æ∫欓∏‘ ¿“æ / ®”π«πÀπŸ∑—ÈßÀ¡¥„π°≈ÿà¡
* ·µ°µà“ß®“°°≈ÿࡧ«∫§ÿ¡Õ¬à“ß¡’π—¬ ”§—≠∑“ß ∂‘µ‘ ∑’Ë p<0.05
+1 À¡“¬∂÷ß °“√‡ª≈’ˬπ·ª≈ß√–¥—∫‡≈Á°πâÕ¬ ( mild degree)

5.0-R= high recovery group

«‘®“√≥å

®“°°“√°√Õ° “√ °—¥¬“·°â°…—¬≈‘Èπ°√–∫◊Õ·°àÀπŸ·√∑«‘ µ“√å∑“ߪ“°„π¢π“¥ Ÿß ÿ¥´÷Ëß
“¡“√∂„À≥⿓¬„π 1 «—π§◊Õ 8.0 °./°°. À√◊Õ‡∑’¬∫‡∑à“°—∫¢π“¥¢Õßµ”√—∫¬“·°â°…—¬≈‘Èπ°√–∫◊Õ 26.71

°./°°. æ∫«à“ ‰¡à∑”„À⇰‘¥Õ“°“√æ‘…‡©’¬∫æ≈—π·≈–ÀπŸ‰¡àµ“¬ √«¡∑—È߉¡à∑”„À⇰‘¥°“√‡ª≈’ˬπ·ª≈ß∑’Ë
º‘¥ª°µ‘∑“ß¡À欓∏‘«‘∑¬“·≈–®ÿ≈欓∏‘«‘∑¬“¢ÕßÕ«—¬«–¿“¬„π ¥—ßπ—Èπ¢π“¥¢Õß “√ °—¥¬“·°â°…—¬
≈‘Èπ°√–∫◊Õ∑’Ë∑”„ÀâÀπŸ·√∑µ“¬√âÕ¬≈– 50 (LD ¡’§à“¡“°°«à“ 8.0 °./°°./«—π ·≈–Õ“®®—¥«à“Õ¬Ÿà„π
50
°≈ÿà¡ “√∑’ˉ¡à‡ªìπæ‘… (Practically Non-toxic) ‡¡◊ËÕ„™â Hodge and Sterner Scale (11)
°“√»÷°…“æ‘…°÷Ë߇√◊ÈÕ√—ߢÕß “√ °—¥¬“·°â°…—¬≈‘Èπ°√–∫◊Õ„πÀπŸ·√∑«‘ µ“√å ‚¥¬ªÑÕπ “√
°—¥¬“·°â°…—¬≈‘Èπ°√–∫◊Õ¢π“¥ 0.5, 2.5, 5.0 °./°°./«—π À√◊Õ‡∑’¬∫‡∑à“°—∫¢π“¥¢Õ߬“·°â°…—¬≈‘Èπ